Literature DB >> 29760004

Clinical Reasoning: A 77-year-old man presenting with episodic expressive aphasia.

Alice Shanklin1, Andrew Cox1, Hamdy M A Ahmed1, Alicia Lieberman1, Ania Busza2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29760004      PMCID： PMC5957309          DOI： 10.1212/WNL.0000000000005525

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  16 in total

1.  A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

Authors:  Carol A Langford; David Cuthbertson; Steven R Ytterberg; Nader Khalidi; Paul A Monach; Simon Carette; Philip Seo; Larry W Moreland; Michael Weisman; Curry L Koening; Antoine G Sreih; Robert Spiera; Carol A McAlear; Kenneth J Warrington; Christian Pagnoux; Kathleen McKinnon; Lindsy J Forbess; Gary S Hoffman; Renée Borchin; Jeffrey P Krischer; Peter A Merkel
Journal:  Arthritis Rheumatol       Date:  2017-03-03       Impact factor: 10.995

2.  Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.

Authors:  Justin C Kao; Bing Liao; Svetomir N Markovic; Christopher J Klein; Elie Naddaf; Nathan P Staff; Teerin Liewluck; Julie E Hammack; Paola Sandroni; Heidi Finnes; Michelle L Mauermann
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

Review 3.  Rheumatic and Musculoskeletal Immune-Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature.

Authors:  Laura C Cappelli; Anna Kristina Gutierrez; Clifton O Bingham; Ami A Shah
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-09-21       Impact factor: 4.794

4.  Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis.

Authors:  Miguel A Gonzalez-Gay; Tomas R Vazquez-Rodriguez; Ines Gomez-Acebo; Robustiano Pego-Reigosa; Maria J Lopez-Diaz; Matilde C Vazquez-Triñanes; Jose A Miranda-Filloy; Ricardo Blanco; Trinidad Dierssen; Carlos Gonzalez-Juanatey; Javier Llorca
Journal:  Medicine (Baltimore)       Date:  2009-07       Impact factor: 1.889

Review 5.  Gemcitabine: vascular toxicity and prothrombotic potential.

Authors:  Constantin A Dasanu
Journal:  Expert Opin Drug Saf       Date:  2008-11       Impact factor: 4.250

6.  3T MRI reveals extra- and intracranial involvement in giant cell arteritis.

Authors:  S Siemonsen; C Brekenfeld; B Holst; A-K Kaufmann-Buehler; J Fiehler; T A Bley
Journal:  AJNR Am J Neuroradiol       Date:  2014-08-28       Impact factor: 3.825

7.  Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; D E Kargman; Q Gu; M C Zamanillo
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

8.  Trial of Tocilizumab in Giant-Cell Arteritis.

Authors:  John H Stone; Katie Tuckwell; Sophie Dimonaco; Micki Klearman; Martin Aringer; Daniel Blockmans; Elisabeth Brouwer; Maria C Cid; Bhaskar Dasgupta; Juergen Rech; Carlo Salvarani; Georg Schett; Hendrik Schulze-Koops; Robert Spiera; Sebastian H Unizony; Neil Collinson
Journal:  N Engl J Med       Date:  2017-07-27       Impact factor: 91.245

9.  Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study.

Authors:  Delphine Larivière; Karim Sacre; Isabelle Klein; Fabien Hyafil; Laurence Choudat; Marie-Paule Chauveheid; Thomas Papo
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade.

Authors:  Alfred Zippelius; Frank Stenner-Liewen; Heinz Läubli; Jürgen Hench; Michal Stanczak; Ingmar Heijnen; Alexandros Papachristofilou; Stephan Frank
Journal:  J Immunother Cancer       Date:  2017-06-20       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.